Page last updated: 2024-11-06

hydroxyguanidine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-hydroxyguanidine : A member of the class of guanidines that is guanidine in which one of the hydrogens attached to the nitrogen at position 1 is substituted by a hydroxy group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID80668
CHEMBL ID309499
CHEBI ID43089
MeSH IDM0094340

Synonyms (28)

Synonym
CHEMBL309499
(diaminomethylene)(hydroxy)ammonium hydrogen sulfate
13115-21-4
nsc529357
nsc-529357
guanidine, hydroxy-
HSCI1_000284
HGU ,
n-hydroxyguanidine
DB03770
hydroxyguanidine
1-hydroxyguanidine
CHEBI:43089 ,
2-hydroxyguanidine
nsc 529357
AKOS009144657
unii-8767f421t7
8767f421t7 ,
guanidine, n-hydroxy-
WFBHRSAKANVBKH-UHFFFAOYSA-N
Q-201219
DTXSID00156915
J-005946
n''-hydroxyguanidine
urea, oxime
Q27094667
CS-0306684
EN300-72350

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" The most promising prodrug candidates, amidoxime ester 7 and N-hydroxyguanidine ester 8, were subjected to in vivo bioavailability studies."( Zanamivir Amidoxime- and N-Hydroxyguanidine-Based Prodrug Approaches to Tackle Poor Oral Bioavailability.
Clement, B; Hoffmann, A; Kotthaus, J; Müller-Fielitz, H; Raasch, W; Riebling, L; Schade, D; Schmidtke, M, 2015
)
0.95
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
antiviral agentA substance that destroys or inhibits replication of viruses.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
guanidinesAny organonitrogen compound containing a carbamimidamido (guanidino) group. Guanidines have the general structure (R(1)R(2)N)(R(3)R(4)N)C=N-R(5) and are related structurally to amidines and ureas.
one-carbon compoundAn organic molecular entity containing a single carbon atom (C1).
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID125180Compound was tested for 50% inhibitory dose against Moloney sarcoma virus1984Journal of medicinal chemistry, Feb, Volume: 27, Issue:2
Novel N-hydroxyguanidine derivatives as anticancer and antiviral agents.
AID197974Inhibition of ribonucleoside diphosphate reductase from rat Novikoff tumor1983Journal of medicinal chemistry, Sep, Volume: 26, Issue:9
Studies of N-hydroxy-N'-aminoguanidine derivatives by nitrogen-15 nuclear magnetic resonance spectroscopy and as ribonucleotide reductase inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (50)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (16.00)18.7374
1990's16 (32.00)18.2507
2000's18 (36.00)29.6817
2010's8 (16.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 18.27

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index18.27 (24.57)
Research Supply Index3.93 (2.92)
Research Growth Index4.57 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (18.27)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (6.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other47 (94.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]